Correlation Between Clal Biotechnology and Photomyne

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Photomyne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Photomyne into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Photomyne, you can compare the effects of market volatilities on Clal Biotechnology and Photomyne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Photomyne. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Photomyne.

Diversification Opportunities for Clal Biotechnology and Photomyne

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Clal and Photomyne is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Photomyne in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Photomyne and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Photomyne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Photomyne has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Photomyne go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Photomyne

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Photomyne. In addition to that, Clal Biotechnology is 1.77 times more volatile than Photomyne. It trades about -0.01 of its total potential returns per unit of risk. Photomyne is currently generating about 0.08 per unit of volatility. If you would invest  187,800  in Photomyne on September 1, 2024 and sell it today you would earn a total of  90,800  from holding Photomyne or generate 48.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Photomyne

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Photomyne 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Photomyne are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Photomyne sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Photomyne Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Photomyne

The main advantage of trading using opposite Clal Biotechnology and Photomyne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Photomyne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Photomyne will offset losses from the drop in Photomyne's long position.
The idea behind Clal Biotechnology Industries and Photomyne pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data